515
Views
12
CrossRef citations to date
0
Altmetric
Review

Caspofungin: a review of its characteristics, activity, and use in intensive care units

, &
Pages 1213-1220 | Received 12 Dec 2019, Accepted 08 Jul 2020, Published online: 23 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mateusz Szymański, Sandra Chmielewska, Urszula Czyżewska, Marta Malinowska & Adam Tylicki. (2022) Echinocandins – structure, mechanism of action and use in antifungal therapy. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 876-894.
Read now
Daniel Echeverria-Esnal, Clara Martín-Ontiyuelo, Maria Eugenia Navarrete-Rouco, Jaime Barcelo-Vidal, David Conde-Estévez, Nuria Carballo, Marta De-Antonio Cuscó, Olivia Ferrández, Juan Pablo Horcajada & Santiago Grau. (2022) Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review. Expert Review of Anti-infective Therapy 20:2, pages 179-197.
Read now

Articles from other publishers (10)

Puja Keshwania, Narinder Kaur, Jyoti Chauhan, Gajanand Sharma, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi & Waleed H. Almalki. (2023) Superficial Dermatophytosis across the World’s Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges. ACS Omega 8:35, pages 31575-31599.
Crossref
Na Chen & Cheng Jiang. (2023) Antimicrobial peptides: Structure, mechanism, and modification. European Journal of Medicinal Chemistry 255, pages 115377.
Crossref
Zhenfeng Shi, Jie Zhang, Lei Tian, Liang Xin, Chengyuan Liang, Xiaodong Ren & Min Li. (2023) A Comprehensive Overview of the Antibiotics Approved in the Last Two Decades: Retrospects and Prospects. Molecules 28:4, pages 1762.
Crossref
Christiane Contigli, Marcelo Siqueira Valle, Sílvia Catarina Salgado Oloris, Lúcia Pinheiro Santos Pimenta & Jacqueline Aparecida Takahashi. 2023. Natural Secondary Metabolites. Natural Secondary Metabolites 555 605 .
Li Yang, Hangqi Zhu, Mingchun Li & Qilin Yu. (2022) The Tricalbin-Family Endoplasmic Reticulum-Plasma Membrane Tethering Proteins Attenuate ROS-Involved Caspofungin Sensitivity in Candida albicans. Microbiology Spectrum 10:6.
Crossref
Meng-Si Ye, Hua-Le Chen, Cai-Xia Liu, Ai-Juan Ren, Hai-Wei Yang & Shi-Shi Wang. (2022) Caspofungin at sub-inhibitory concentration promotes the formation of Candida albicans persister cells. Journal of Applied Microbiology 133:4, pages 2466-2473.
Crossref
Hoshyar Saadi Ali, Hemn A.H. Barzani, Yavuz Yardim & Zühre Şentürk. (2022) First electrochemical study of a potent antifungal drug caspofungin: Application to its enhanced voltammetric sensing based on the performance of boron-doped diamond electrode in CTAB-mediated measurements. Diamond and Related Materials 125, pages 109031.
Crossref
Saraswathi Nagaraj, Sivakami Manivannan & Shoba Narayan. (2021) Potent antifungal agents and use of nanocarriers to improve delivery to the infected site: A systematic review. Journal of Basic Microbiology 61:10, pages 849-873.
Crossref
Maria Lazaridou, Stavroula Nanaki, Alexandra Zamboulis, Chrysanthi Papoulia, Konstantinos Chrissafis, Panagiotis A. Klonos, Apostolos Kyritsis, Souzan Vergkizi-Nikolakaki, Margaritis Kostoglou & Dimitrios N. Bikiaris. (2021) Super absorbent chitosan-based hydrogel sponges as carriers for caspofungin antifungal drug. International Journal of Pharmaceutics 606, pages 120925.
Crossref
Gérard Vergoten & Christian Bailly. (2021) In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CLpro) and SARS-CoV-2 (Mpro). In Silico Pharmacology 9:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.